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Mediastinal growing teratoma syndrome after cisplatin-based
chemotherapy and radiotherapy for intracranial germinoma
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Nonseminomatous germ cell tumor (NSGCT) has beentreated with cisplatin-based chemotherapeutic regi-mens. In cases of good response of tumor to chemo-therapy, elevated tumor markers such as alpha-feto-
protein (AFP) and human chorionic gonadotropin (hCG) return to
normal with tumor shrinkage. However, a small proportion of
cases demonstrate tumor growth during or after the treatment. This
distinctive situation was first described for testicular NSGCT by
Logothetis and colleagues1 and was designated the growing tera-
toma syndrome (GTS). In this report we describe GTS of the
mediastinum after cisplatin-based chemotherapy and radiotherapy
for intracranial germ cell tumor.
Clinical Summary
A 20-year-old man with a rapidly growing mediastinal tumor was
referred to our department. One month before, tumors in the pineal
and the suprasellar regions had been found, with bitemporal hemi-
anopia. Results of routine blood chemistry and coagulation studies
were normal; however, serum AFP and hCG were increased to 447
ng/mL and 240 ng/ml, respectively. Serum carcinoembryonic an-
tigen level was normal. The patient underwent partial resection of
the suprasellar lesion for pathologic diagnosis. The pathologic
diagnosis in the lesion was germinoma. Thereafter, the patient
underwent chemotherapy consisting of ifosfamide, cisplatin, and
etoposide followed by 20 Gy local irradiation. The intracranial
lesions completely disappeared. Serum AFP and hCG were de-
creased to within normal limits.
After these therapies, a chest roentgenogram accidentally dis-
closed a mass located in the mediastinum. Chest computed tomog-
raphy showed a round and lobulated mass in the anterosuperior
mediastinum. The size of the mass rapidly increased (Figure 1).
Tumor doubling time was calculated at 34.3 days. The tumor
showed no response to 20 Gy irradiation. Gallium scintigraphy
showed a slightly intense mediastinal enhancement region and no
other lesion outside the chest. Histologic examination of a percu-
taneous needle biopsy specimen showed necrotic and fibrous con-
nective tissue.
A median sternotomy was performed. The tumor was encap-
sulated in the thymic tissue. A complete resection was performed
with negative margins.
On pathologic examination, the specimen of the mediastinal
tumor was characteristic of mature teratoma. The tumor consisted
of mature squamous epithelium with immature glandular struc-
tures. Immature structure tested immunohistochemically positive
for carcinoembryonic antigen and keratin but negative for AFP and
hCG (Figure 2, A). However, the immature component was less
than 10% of the tumor. Retrospective pathologic examination in
the intracranial lesion resected before chemoradiotherapy revealed
pure germinoma with negative results of immunohistochemical
testing for AFP and hCG (Figure 2, B).
The postoperative course was uneventful. At 8-month follow-
up, the patient is doing well with no evidence of disease.
Discussion
Mediastinal germ cell tumors are heterogeneous groups of benign
and malignant neoplasm thought to originate from primitive germ
cells misplaced in the mediastinum.2 Teratoma, the most common
mediastinal germ cell tumor, is classified as either mature tera-
toma, well-differentiated histologically and containing less than
10% fetal tissue, or immature teratoma, containing more than 10%
fetal tissue.3
The definition of GTS encompasses three criteria: first, nor-
malization of previously elevated serum tumor marker AFP or
hCG, second, an increase in tumor size during or after chemother-
apy given for NSGCT, and third, the absence of any NSGCT
component other than mature teratoma in the tumor resected.1 The
incidence of GTS among patients with metastatic NSGCT is
between 1.9% and 7.6%.1,4
In our case, serum AFP and hCG levels had returned to normal
after the chemoradiotherapy for intracranial lesions. The residual
mediastinal tumor was disclosed accidentally and grew after che-
moradiotherapy. The specimen of the mediastinal tumor was his-
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Figure 1. Rapid-growing mediastinal tumor. Tumor doubling time was 34.3 days. A, Chest computed tomographic
findings at admission to our department; B, 12 days after admission; C,19 days after admission.
Figure 2. Tumor consists of mature squamous epithelium with immature glandular structures (A-1). Mature
squamous epithelium stains positively for keratin (A-2). Immature glandular structure (A-3) is less than 10% in the
tumor and positive for carcinoembryonic antigen (A-4) but stains negatively for AFP and hCG. Intracranial tumor
partially resected before chemoradiotherapy (B) was pure germinoma and negative for AFP and hCG.
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tologically determined to be mature teratoma. However, the patho-
logical findings of the needle-biopsy specimen after
chemoradiotherapy included necrotic and fibrous connective tis-
sue. These results may suggest the additional existence of an
NSGCT component other than teratoma in our case, which could
secrete AFP or hCG and disappeared after the therapies.
With respect to primary mediastinal GTS, Chen and col-
leagues5 first reported the increasing immature teratoma as GTS.
Afifi and associates6 stated that Chen and colleagues’ case did not
fulfill the criteria of GTS because the AFP level did not return to
normal and mature teratoma was not documented after resection.
Iyoda and coworkers7 noted that immature component was very
small in their case of GTS and reviewed 4 cases of primary
mediastinal GTS from the previous reports. Our case represents the
5th reported case of primary mediastinal GTS.
Primary intracranial germ cell tumors are rare malignancies.
The tumors of the pineal gland comprise germinoma (45%), NS-
GCT (16%), pineal parenchymal gliomas (15%), and other lipo-
mas, cysts, metastases, and meningioma (7%). O’Callaghan and
colleagues8 reported intracranial GTS in an NSGCT of the pineal
gland.
The biopsy specimen of the intracranial tumor in our case
represented pure germinoma histologically because test results
were negative for AFP and hCG after chemoradiotherapy. It is
unclear whether the intracranial tumor was a metastatic lesion
from the mediastinal heterogeneous tumors. We regard our case as
a primarily double cancer case with intracranial and mediastinal
germ cell tumors, because these tumors arose in the likely sites
each as primary germ cell tumor rather than as a metastasis.
Regarding treatment for NSGCT, surgical resection of a resid-
ual mass is usually performed only in patients with normal levels
of tumor markers. Previous reports of primary mediastinal GTS
have noted that complete resection of residual mass after chemo-
therapy or chemoradiotherapy could be successful with good prog-
nosis.5-7,10
Andre and associates9 reported that 5-year overall survival and
progression-free survival of GTS are 90% and 73%, respectively.
In the reported 4 cases of primary mediastinal GTS, there was 1
case with local recurrence 5 months after the complete resection.10
The other cases had no recurrence for 3, 24, and 27, months after
the operation.5-7
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